Tamonan, Annie M.
HRN: 21-29-62 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/11/2022
CEFTRIAXONE 1G (VIAL)
05/11/2022
05/17/2022
IV
1G
Q12
Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bone & Joint Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: No Further Investigation
Overall appropriateness: No Indication Inappropriate